After 43 years in the industry, Southeastern Grocers VP pharmacy John Fegan will be retiring, bringing to a close a career that included a focus on expanding pharmacy services to improve patient health.
Drug Store News hosted an exclusive reception last week in Providence, R.I., to mark the release of the October 2016 issue of DSN, which featured the special cover feature, “CVS Doubles Down on Health.” In all, more than 100 guests attended, including about 25 CVS executives and select members of the vendor community.
Drug Store News recently spoke with Walgreens Specialty Pharmacy group VP Gerry Gleeson about the company’s approach to specialty and the importance of a focus on patient care and pharmacist education in that space.
Drug overdoses have become the leading cause of accidental death in the United States, with 47,055 people dying in 2014 as a result of lethal drug overdoses — 18,893 of which were related to prescription pain relievers. One of the critical first lines of defense, the drug naloxone can reverse the effects of an overdose. But until recently it could only be accessed by prescription.
CVS Health rocked the industry in 2014 when it removed cigarettes and tobacco from its pharmacy shelves in an effort to promote health and reduce chronic illnesses associated with tobacco-use. Now, the retailer is taking yet another stance against tobacco-use with a hefty $50 million initiative to help deliver the nation’s first tobacco-free generation.
The ExtraCare loyalty program has grown to become CVS Health’s crown jewel. In 2015, the program — now in its 15th year — helped drive nearly $4 billion in savings for its roughly 70 million active cardholders. More important, it has emerged as the key engine driving CVS Health’s personalization efforts — a critical component of the company’s five-pillar strategy to reenergize its front-end business.